Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions
K. Rivet Amico(University of Cape Town), Adaora A. Adimora(Office of Infectious Diseases), Shobha Swaminathan(Rutgers, The State University of New Jersey), Sally Hodder(West Virginia University), Raphael J. Landovitz(APLA Health), Marybeth McCauley(Family Health International 360), Jing Wang(Longgang Central Hospital), Catalina Ramirez(University of North Carolina at Chapel Hill), Roy M. Gulick(New York University), Brooke E. E. Montgomery(Pathways Behavioral Services), Margaret R Caplan(University of California, Los Angeles), Noshima Y Darden‐tabb(University of North Carolina at Chapel Hill), Jennifer M. Stewart(Johns Hopkins University), Timothy Wilkin(Cornell University)
Cited by 28
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891